We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+24.4%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.78B
AUM Growth
-$224M
Cap. Flow
-$162M
Cap. Flow %
-9.08%
Top 10 Hldgs %
64.26%
Holding
62
New
5
Increased
1
Reduced
29
Closed
5

Top Buys

Rank Stock Value
1
CELC icon
Celcuity
CELC
+$12.8M
2
XFOR icon
X4 Pharmaceuticals
XFOR
+$8.23M
3
ACRV icon
Acrivon Therapeutics
ACRV
+$6.11M
4
MIMO.WS.C
Airspan Networks Holdings Inc Warrants
MIMO.WS.C
+$671K
5
MIMO.WS.B
Airspan Networks Holdings Inc Warrants
MIMO.WS.B
+$663K

Top Sells

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$56.6M
2
ACLX
Arcellx
ACLX
+$46M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$32.5M
4
AKUS
Akouos Inc
AKUS
+$29.1M
5
IVA
Inventiva
IVA
+$19.3M

Sector Composition

Rank Sector Weight
1 Healthcare 71.35%
2 Consumer Staples 10.55%
3 Technology 10.5%
4 Industrials 7.01%
5 Communication Services 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUPH icon
26
Aurinia Pharmaceuticals
AUPH
$2.05B
$17.1M 0.96%
3,969,834
– –
XFOR icon
27
X4 Pharmaceuticals
XFOR
$427M
$11.7M 0.65%
391,226
+173,787
+80% +$8.23M
OKUR
28
OnKure Therapeutics
OKUR
$168M
$11.2M 0.63%
478,549
-143
-0% -$3.79K
BZFD icon
29
BuzzFeed
BZFD
$94.9M
$10.6M 0.59%
3,833,473
– –
NOTE
30
DELISTED
FiscalNote
NOTE
$9.65M 0.54%
141,194
– –
TUYA
31
Tuya Inc
TUYA
$1.07B
$9.43M 0.53%
4,934,640
– –
CSBR icon
32
Champions Oncology
CSBR
$73.2M
$7.73M 0.43%
1,713,720
– –
GOSS icon
33
Gossamer Bio
GOSS
$87.4M
$7.52M 0.42%
3,467,406
– –
IVA
34
Inventiva
IVA
$1.15B
$7M 0.39%
1,462,586
-4,110,367
-74% -$19.3M
BILL icon
35
BILL Holdings
BILL
$4.77B
$6.84M 0.38%
66,070
-30
-0% -$3.6K
BDTX icon
36
Black Diamond Therapeutics
BDTX
$110M
$6.21M 0.35%
3,448,757
-1,088
-0% -$1.96K
AFMD
37
DELISTED
Affimed
AFMD
$5.49M 0.31%
442,649
– –
SNTI icon
38
Senti Biosciences Holdings
SNTI
$10.7M
$5.35M 0.3%
442,615
-358
-0.1% -$8.73K
LXRX icon
39
Lexicon Pharmaceuticals
LXRX
$1.06B
$4.55M 0.26%
2,382,286
– –
ACRV icon
40
Acrivon Therapeutics
ACRV
$73.6M
$4.44M 0.25%
+481,677
New +$6.11M
XERS icon
41
Xeris Biopharma Holdings
XERS
$1.35B
$4.32M 0.24%
3,246,785
– –
SYBX
42
DELISTED
Synlogic
SYBX
$3.21M 0.18%
281,929
-32
-0% -$391
MRKR icon
43
Marker Therapeutics
MRKR
$18.5M
$2.85M 0.16%
1,071,429
– –
STSA
44
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$2.69M 0.15%
2,992,958
-150,000
-5% -$435K
EAR
45
DELISTED
Eargo, Inc. Common Stock
EAR
$2.6M 0.15%
226,010
-32
-0% -$411
INZY
46
DELISTED
Inozyme Pharma
INZY
$2.56M 0.14%
2,437,689
-6,690
-0.3% -$11.7K
UTRS
47
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$2.23M 0.13%
499,956
-141
-0% -$936
LITS
48
Lite Strategy Inc
LITS
$31.6M
$2.08M 0.12%
426,654
– –
RGLS
49
DELISTED
Regulus Therapeutics
RGLS
$1.98M 0.11%
1,445,114
-1
-0% -$2
MIMO
50
DELISTED
Airspan Networks Holdings Inc
MIMO
$1.81M 0.1%
1,382,300
-152,333
-10% -$297K
1
2
3

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
GD
Grandfield & Dodd New York $1.77B AUM 23.43% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

NEA Management Company's Q4 2022 Portfolio in Review

As of Q4 2022, NEA Management Company held 62 positions worth $1.78B, down 11% from $2B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

NEA Management Company withdrew a net $162M in Q4 2022, closing 5 positions and reducing 29 holdings. Its most notable exit was AVEO Pharmaceuticals, Inc., an estimated $32.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 67% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, NEA Management Company opened a new position in Celcuity worth $17.5M.

  • NEA Management Company's largest Q4 2022 buy was Celcuity: 1,250,001 shares worth $17.5M.
  • NEA Management Company added most to X4 Pharmaceuticals in Q4 2022, an estimated $8.23M increase.
  • NEA Management Company's biggest Q4 2022 reduction was IonQ, cutting an estimated $56.6M.
  • NEA Management Company fully exited AVEO Pharmaceuticals, Inc. in Q4 2022, selling an estimated $32.5M.
  • NEA Management Company's ten largest holdings make up 64% of its $1.78B portfolio in Q4 2022.
  • NEA Management Company opened 5 new positions and closed 5 in Q4 2022.
  • NEA Management Company's portfolio value fell 11% quarter-over-quarter to $1.78B.

Based on NEA Management Company's 13F filing for Q4 2022, filed 10 Feb 2023.